Om oss
Om Guard Therapeutics
Vision och strategi
Styrelse
Ledning
Forskning & Utveckling
Akuta njurskador
ROSgard
Vetenskapligt koncept
Klinisk utveckling
Patent
Publikationer
Investerare
Finansiell kalender
Finansiella rapporter
Eventkalender
Emissioner
Aktieinformation
Bolagsstämma
Bolagsstyrning
Bolagsordning
Certified Adviser
Nyheter & media
Pressmeddelanden
Analyser och presentationer
Nyheter
Prenumerera
Kontakt
Eng
Sök
Analyser och presentationer
Analyser
04 jun 2020 / Monocl valuation report for cardiac surgery AKI 2018
https://guardtherapeutics.com/assets/uploads/Monocl-valuation-report_20181129.pdf
04 jun 2020 / Redeye valuation report 2019
https://guardtherapeutics.com/assets/uploads/Redeye-valuation-report_20190922.pdf
Presentationer
04 jun 2020 / Redeye, lär känna vd Tobias Agervald
https://guardtherapeutics.com/p/redeye-lar-kanna-vd-tobias-agervald
02 apr 2020 / Redeye, Investor Forum Online
https://redeye.solidtango.com/widgets/embed/dj7dg5ux?auto_play=true
27 jan 2020 / Redeye, intervju med vd Tobias Agervald
https://guardtherapeutics.com/p/redeye-intervju-med-vd-tobias-agervald-guard-therapeutics
29 nov 2019 / ASN presentation (poster)
https://guardtherapeutics.com/assets/uploads/2019-10-31-ASN_Poster.pdf